Amoxiplus

Medicinal product

(Invented) name

Amoxiplus

Active substance (s)

Amoksicilinas/Klavulano rūgštis

Strength

1000 mg/200 mg

Pharmaceutical form

milteliai injekciniam ar infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR02, Amoxicillin and beta-lactamase inhibitor

Marketing authorisation holder

UAB Eletis Medica, Lietuva

Date of authorisation

2020-04-30

Date of renewal

Documents

1282_Amoxiplus 1000_200mg_milt_inj_inf_tirp_PZPL_2020-04-30.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

flakone yra	1 vnt.
Amoksicilinas	1000 mg
Klavulano rūgštis	200 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
104002	90107	1090107	flakonas	N25	ASPĮ	Receptinis	LT/L/20/1282/001	Netiekiama	2025-10-30	2025-11-21	No	-	-	Download

Stadijos

Data	Stadija
2020-04-30	Registruotas